Ionis Pharmaceuticals: H.C. Wainwright cuts target price to $70 from $100
IONS•H.C. Wainwright cut its target price for Ionis Pharmaceuticals to $70 from $100.
Related News
IHS Holding announces availability of third-quarter 2026 earnings release
IHS•
Ardelyx to participate in fireside chat at Jefferies Global Healthcare Conference
ARDX•
Dyadic partners with BRIG BIO, Strive Nutrition to develop precision-fermented alpha-lactalbumin
DYAI•
LENSAR Q3 revenue slightly misses estimates on slower surgical scheduling
LNSR•
Adtran Networks Q3 2026 operating profit more than triples year on year to EUR 9.13 million
ADTN•